Cargando…

Effects of different urodynamic characteristics on therapeutic outcomes of overactive bladder medication in a real-life clinical practice

OBJECTIVE: This study retrospectively investigated the influence of urodynamic parameters and patient characteristics on success rates among patients with overactive bladder (OAB) and urodynamic detrusor overactivity (DO). MATERIALS AND METHODS: Consecutive patients with OAB and urodynamic DO initia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Hsiu-Jen, Kuo, Hann-Chorng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791855/ https://www.ncbi.nlm.nih.gov/pubmed/36578645 http://dx.doi.org/10.4103/tcmj.tcmj_264_20

Ejemplares similares

Individualizing medical treatment of overactive bladder
por: Kuo, Hann-Chorng
Publicado: (2018)

Urodynamic prognostic factors for large post-void residual urine volume after intravesical injection of onabotulinumtoxinA for overactive bladder
por: Hsiao, Sheng-Mou, et al.
Publicado: (2017)

Practical points in the medical treatment of overactive bladder and nocturia in the elderly
por: Chen, Jing-Liang, et al.
Publicado: (2016)

Urodynamic Detrusor Overactivity in Patients with Overactive Bladder Symptoms
por: Al-Ghazo, Mohammed A., et al.
Publicado: (2011)

Video-urodynamic characteristics of non-neurogenic, idiopathic underactive bladder in men – A comparison of men with normal tracing and bladder outlet obstruction
por: Jiang, Yuan-Hong, et al.
Publicado: (2017)

Practical Aspects of Botulinum Toxin-A Treatment in Patients With Overactive Bladder Syndrome
por: Liao, Chun-Hou, et al.
Publicado: (2015)

Comparative study of different combinations of mirabegron and antimuscarinics in treatment for overactive bladder syndrome in elderly patients
por: Kuo, Yuh-Chen, et al.
Publicado: (2021)

Urodynamic characteristics of detrusor underactivity in women with voiding dysfunction
por: Yang, Tsai-Hwa, et al.
Publicado: (2018)

Urodynamic characteristics of lower urinary tract of patients with idiopathic overactive bladder
por: Dekhtiar, Yuriy M., et al.
Publicado: (2019)

Factors Associated with Therapeutic Efficacy of Intravesical OnabotulinumtoxinA Injection for Overactive Bladder Syndrome
por: Hsiao, Sheng-Mou, et al.
Publicado: (2016)

How to choose appropriate medication for overactive bladder: Findings from the largest integrated clinical trial database analysis of mirabegron studies
por: Kuo, Hann-Chorng
Publicado: (2020)

Differences in the Urinary Microbiome of Patients with Overactive Bladder Syndrome with and without Detrusor Overactivity on Urodynamic Measurements
por: Javan Balegh Marand, Aida, et al.
Publicado: (2023)

Adverse Events of Intravesical OnabotulinumtoxinA Injection between Patients with Overactive Bladder and Interstitial Cystitis—Different Mechanisms of Action of Botox on Bladder Dysfunction?
por: Kuo, Yuh-Chen, et al.
Publicado: (2016)

Identifying occult bladder outlet obstruction in women with detrusor-underactivity-like urodynamic profiles
por: Chow, Po-Ming, et al.
Publicado: (2021)

Treating overactive bladder symptoms after transurethral prostatic surgery for benign prostatic hyperplasia – Which medication to choose?
por: Lee, Cheng-Ling, et al.
Publicado: (2023)

The Overactive Bladder Symptom Score, International Prostate Symptom Score–Storage Subscore, and Urgency Severity Score in Patients With Overactive Bladder and Hypersensitive Bladder: Which Scoring System is Best?
por: Chuang, Fei-Chi, et al.
Publicado: (2018)

Urodynamic and Bladder Diary Factors Predict Overactive Bladder-wet in Women: A Comparison With Overactive Bladder-dry
por: Hsiao, Sheng-Mou, et al.
Publicado: (2019)

Clinical application of intravesical botulinum toxin type A for overactive bladder and interstitial cystitis
por: Chen, Jing-Liang, et al.
Publicado: (2020)

Efficacy of Intravesical Botulinum Toxin A Injection in the Treatment of Refractory Overactive Bladder in Children
por: Fan, Yu-Hua, et al.
Publicado: (2023)

Recurrent urinary tract infection in women and overactive bladder – Is there a relationship?
por: Ke, Qian-Sheng, et al.
Publicado: (2020)

A Precision Urodynamic Diagnosis is Essential for Successful Treatment of Lower Urinary Tract Dysfunction
por: Kuo, Hann-Chorng
Publicado: (2022)

Urodynamic Mechanisms Underlying Overactive Bladder Symptoms in Patients With Parkinson Disease
por: Vurture, Gregory, et al.
Publicado: (2019)

Video-Urodynamic Characteristics and Predictors of Switching from Botulinum Neurotoxin a Injection to Augmentation Enterocystoplasty in Spinal Cord Injury Patients
por: Lin, Chih-Chieh, et al.
Publicado: (2022)

Will repeated botulinum toxin A improve detrusor overactivity and bladder compliance in patients with chronic spinal cord injury?
por: Chen, Sheng-Fu, et al.
Publicado: (2020)

Overactive bladder with urodynamic study-induced bladder pain: An overactive bladder subtype with symptoms similar to those of interstitial cystitis/painful bladder syndrome
por: Mu, Hsueh-Yu, et al.
Publicado: (2023)

The Pharmacological Mechanism of Diabetes Mellitus-Associated Overactive Bladder and Its Treatment with Botulinum Toxin A
por: Wang, Chung-Cheng, et al.
Publicado: (2020)

The clinical application of intravesical botulinum toxin A injection in patients with overactive bladder and interstitial cystitis
por: Jiang, Yuan-Hong, et al.
Publicado: (2022)

Increased Serum Adipokines Implicate Chronic Inflammation in the Pathogenesis of Overactive Bladder Syndrome Refractory to Antimuscarinic Therapy
por: Liu, Hsin-Tzu, et al.
Publicado: (2013)

Evaluation of female overactive bladder using urodynamics: relationship with female voiding dysfunction
por: Cho, Kang Jun, et al.
Publicado: (2015)

Urodynamic outcome of parasacral transcutaneous electrical neural stimulation for overactive bladder in children
por: Barroso, Ubirajara, et al.
Publicado: (2015)

Urodynamic efficacy of fesoterodine for the treatment of neurogenic detrusor overactivity and/or low compliance bladder
por: Kaga, Kanya, et al.
Publicado: (2020)

Recent research on the role of urodynamic study in the diagnosis and treatment of male lower urinary tract symptoms and urinary incontinence
por: Jiang, Yuan-Hong, et al.
Publicado: (2017)

Relationship between Body Mass Index and Overactive Bladder in Women and Correlations with Urodynamic Evaluation
por: Al-Shaiji, Tariq F., et al.
Publicado: (2012)

Changes of lower urinary tract function after robot-assisted radical prostatectomy: An urodynamic follow-up within 1 year
por: Jiang, Yuan-Hong, et al.
Publicado: (2022)

Efficacy and Safety of Intravesical OnabotulinumtoxinA Injection on Elderly Patients with Chronic Central Nervous System Lesions and Overactive Bladder
por: Jiang, Yuan-Hong, et al.
Publicado: (2014)

Duration of Antimuscarinic Administration for Treatment of Overactive Bladder Before Which One Can Assess Efficacy: An Analysis of Predictive Factors
por: Hsiao, Sheng-Mou, et al.
Publicado: (2015)

Urine biomarkers in ESSIC type 2 interstitial cystitis/bladder pain syndrome and overactive bladder with developing a novel diagnostic algorithm
por: Jiang, Yuan-Hong, et al.
Publicado: (2021)

Presence of Cleaved Synaptosomal-Associated Protein-25 and Decrease of Purinergic Receptors P2X3 in the Bladder Urothelium Influence Efficacy of Botulinum Toxin Treatment for Overactive Bladder Syndrome
por: Liu, Hsin-Tzu, et al.
Publicado: (2015)

The impact of urodynamics on treatment and outcomes in women with an overactive bladder: a longitudinal prospective follow-up study
por: Verghese, Tina Sara, et al.
Publicado: (2017)

A comparison of normal and high post-void residual urine and urodynamic parameters in women with overactive bladder
por: Dağdeviren, Hediye, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_60p0872vg64fqkcil897ovto5o